Reverse genetics is a crucial tool for studying virus replication and pathogenesis in negative strand RNA viruses (NSVs). However, its application has been limited by a scarcity of infectious cDNA clones from virulent field strains, as most available clones originate from cell-adapted or attenuated viruses, hindering pathogenesis research. To overcome this, a novel high-throughput system was developed for directly cloning complete NSV genomes into reverse genetics vectors via linear-to-linear RedE/T recombination (LLHR). This method demonstrated reliability by rapidly cloning multiple rabies virus (RABV) full-length genomes, achieving 73% to 88% insertion rates identical to field virus consensus. Recombinant RABVs were successfully recovered, exhibiting comparable growth kinetics, preserved cell type-specific replication, and virulence in mouse models. The system’s flexibility was also confirmed by efficiently cloning an orthobunyavirus L genome segment. This technological advance significantly improves the analysis of virus variability and phenotypical characterization of recombinant viruses at a clonal level boosting future pathogenesis research.
(MKO)
2025年6月24日火曜日
Reverse genetics in high throughput: rapid generation of complete negative strand RNA virus cDNA clones and recombinant viruses thereof
登録:
コメントの投稿 (Atom)
Interferon and TLR genes, but not endogenous bornavirus-like elements, limit BoDV1 replication after intracerebral infection
Borna disease virus 1 (BoDV1) is a neurotropic RNA virus, but the host factors limiting its replication in the brain are not fully understoo...
-
Severe fever with thrombocytopenia syndrome (SFTS) virus poses a major public health threat, with high mortality rates in both humans and ca...
-
Nucleoprotein is important in regulating transcription and replication of Negative-sense RNA viruses. Although the viral RNA-dependent RNA-p...
-
The Human Parainfluenza Virus (HPIV) is an important pathogen that affects the respiratory system in both children and adults. The results s...
0 件のコメント:
コメントを投稿